Cargando…

Time Course of the Development of Nonalcoholic Fatty Liver Disease in the Otsuka Long-Evans Tokushima Fatty Rat

Nonalcoholic fatty liver disease (NAFLD) is considered a hepatic manifestation of metabolic syndrome. In this study, we investigated histological and biochemical changes in NAFLD and the gene expression involving de novo lipogenesis in Otsuka Long-Evans Tokushima fatty (OLETF) rats. We used OLETF ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Yi-Sun, Fang, Cheng-Hu, So, Byung-Im, Park, Jun-Young, Lee, Yonggu, Shin, Jeong Hun, Jun, Dae Won, Kim, Hyuck, Kim, Kyung-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666266/ https://www.ncbi.nlm.nih.gov/pubmed/23737763 http://dx.doi.org/10.1155/2013/342648

Ejemplares similares

Anti-Obesity Effects of Granulocyte-Colony Stimulating Factor in Otsuka-Long-Evans-Tokushima Fatty Rats
por: Lee, Yonggu, et al.
Publicado: (2014)

Effects of Rosiglitazone on Inflammation in Otsuka Long-Evans Tokushima Fatty Rats
por: Lee, Jin Woo, et al.
Publicado: (2010)

Vascular Aldosterone Production at the Pre-Diabetic Stage of Young Otsuka Long-Evans Tokushima Fatty (OLETF) Rats, Compared with Long-Evans Tokushima Otsuka (LETO) Rats
por: Matsuzawa, Yoko, et al.
Publicado: (2013)

Obesity in the Otsuka Long Evans Tokushima Fatty Rat: Mechanisms and Discoveries
por: Bi, Sheng, et al.
Publicado: (2016)

Femoral bone structure in Otsuka Long-Evans Tokushima Fatty rats
por: Minematsu, Akira, et al.
Publicado: (2016)

Effects of granulocyte-colony stimulating factor (G-CSF) on diabetic cardiomyopathy in Otsuka Long-Evans Tokushima Fatty rats
por: Lim, Young-Hyo, et al.
Publicado: (2011)

Alpha-lipoic acid attenuates cardiac fibrosis in Otsuka Long-Evans Tokushima Fatty rats
por: Lee, Jung Eun, et al.
Publicado: (2012)

Effects of Moderate Alcohol Intake in the Bladder of the Otsuka Long Evans Tokushima Fatty Diabetic Rats
por: Bae, Woong Jin, et al.
Publicado: (2015)

Korean Red Ginseng attenuates type 2 diabetic cardiovascular dysfunction in Otsuka Long-Evans Tokushima Fatty rats
por: Hossain, Mohammad Amjad, et al.
Publicado: (2020)

Beneficial Effects of Aerobic Exercise Training Combined with Rosiglitazone on Glucose Metabolism in Otsuka Long Evans Tokushima Fatty Rats
por: Piao, Shan-Ji, et al.
Publicado: (2017)

High Susceptibility to Zymbal Gland and Intestinal Carcinogenesis in Diabetic Otsuka Long-Evans Tokushima Fatty Rats
por: Hafez, Ezar, et al.
Publicado: (2011)

Effect of fosinopril on the renal cortex protein expression profile of Otsuka Long-Evans Tokushima Fatty rats
por: Li, Zhiguo, et al.
Publicado: (2020)

Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes
por: Kim, Kyoung Soo, et al.
Publicado: (2012)

Effect of anti‐oxidants, Ricetrienol and α‐tocopherol, on adipocytokine abnormalities and fatty liver in Otsuka Long‐Evans Tokushima Fatty diabetic rats
por: Tatsumi, Kunihiro, et al.
Publicado: (2010)

Response: Effects of Rosiglitazone on Inflammation in Otsuka Long-Evans Tokushima Fatty Rats (Korean Diabetes J 2010;34:191-9)
por: Kim, Eun Sook
Publicado: (2010)

S-Allyl cysteine improves nonalcoholic fatty liver disease in type 2 diabetes Otsuka Long-Evans Tokushima Fatty rats via regulation of hepatic lipogenesis and glucose metabolism
por: Takemura, Shigekazu, et al.
Publicado: (2013)

Letter: Effects of Rosiglitazone on Inflammation in Otsuka Long-Evans Tokushima Fatty Rats (Korean Diabetes J 2010;34:191-9)
por: Yang, Soo Jin, et al.
Publicado: (2010)

Attenuation of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) Rats with a Combination of Chinese Herbs (Tangshen Formula)
por: Zhang, Haojun, et al.
Publicado: (2011)

d-allulose protects against diabetic nephropathy progression in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes
por: Niibo, Misato, et al.
Publicado: (2022)

Exacerbation of acidosis during ischemia and reperfusion arrhythmia in hearts from type 2 Diabetic Otsuka Long-Evans Tokushima Fatty rats
por: Anzawa, Ryuko, et al.
Publicado: (2007)

Rare sugar d-psicose prevents progression and development of diabetes in T2DM model Otsuka Long-Evans Tokushima Fatty rats
por: Hossain, Akram, et al.
Publicado: (2015)

Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats
por: Li, Jia, et al.
Publicado: (2018)

In Situ Gel Incorporating Disulfiram Nanoparticles Rescues the Retinal Dysfunction via ATP Collapse in Otsuka Long–Evans Tokushima Fatty Rats
por: Deguchi, Saori, et al.
Publicado: (2020)

Effects of acupuncture stimulation on blood glucose concentration in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat, an animal model for type-2 diabetes mellitus
por: Nakamura, Hironori, et al.
Publicado: (2014)

Alteration of Vascular Responsiveness to Uridine Adenosine Tetraphosphate in Aortas Isolated from Male Diabetic Otsuka Long-Evans Tokushima Fatty Rats: The Involvement of Prostanoids
por: Matsumoto, Takayuki, et al.
Publicado: (2017)

Investigation of Metabolism of Exogenous Glucose at the Early Stage and Onset of Diabetes Mellitus in Otsuka Long-Evans Tokushima Fatty Rats Using [1, 2, 3-(13)C]Glucose Breath Tests
por: Kawagoe, Naoyuki, et al.
Publicado: (2016)

Additive effects of cilnidipine, an L-/N-type calcium channel blocker, and an angiotensin II receptor blocker on reducing cardiorenal damage in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes mellitus
por: Mori, Yutaka, et al.
Publicado: (2014)

Reduction of Food Intake by Fenofibrate is Associated with Cholecystokinin Release in Long-Evans Tokushima Rats
por: Park, Mi-Kyoung, et al.
Publicado: (2012)

Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
por: Kim, Kyung-Soo, et al.
Publicado: (2019)

Risk factors in nonalcoholic fatty liver disease
por: Ko, Eunji, et al.
Publicado: (2023)

Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
por: Kim, Kyung-Soo, et al.
Publicado: (2020)

Factors Associated or Related to with Pathological Severity of Nonalcoholic Fatty Liver Disease
por: Park, Kyung Sik, et al.
Publicado: (2004)

G-CSF Prevents Progression of Diabetic Nephropathy in Rat
por: So, Byung-Im, et al.
Publicado: (2013)

Recent research trends and updates on nonalcoholic fatty liver disease
por: Yoo, Jeong-Ju, et al.
Publicado: (2019)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Interaction between sarcopenia and nonalcoholic fatty liver disease
por: Joo, Sae Kyung, et al.
Publicado: (2023)

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
por: Kang, Seong Hee, et al.
Publicado: (2021)

Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”
por: Yoon, Eileen L., et al.
Publicado: (2023)

Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Kim, Gyuri, et al.
Publicado: (2015)

Hepatoprotective Effects of Insect Extracts in an Animal Model of Nonalcoholic Fatty Liver Disease
por: Im, A-Rang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ttun5mapkgigsq2a194gkis099